Faculty profile

Yuliang Wu

ResearcherBiochemistry, Microbiology & ImmunologyUniversity of Saskatchewan

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Saskatchewan directory, so their courses may be missing. Find their university profile.

Yuliang Wu

Researcher

Biochemistry, Microbiology & Immunology

University of Saskatchewan

Saskatoon, Saskatchewan, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 NSERC), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

DDX43 DDX53 DEAD-box protein Helicase KH domain Nucleic acid binding Protein oligomerization

Latest papers

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.
Signal transduction and targeted therapy · 2026
MDS/AML-associated DDX41 helicase facilitates homologous recombination repair by potentially resolving R-loops.
Nucleic acids research · 2026 · senior author
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.
Oncogene · 2025

All 26 publications

Latest funding

Understanding the Role of KH Domain in Helicases
NSERC · 2019 · Principal investigator
$216,000
The role of Q motif in superfamily 2 DNA helicases
NSERC · 2012 · Principal investigator
$155,000

All 2 grants and awards

26 publications.

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

Price JDW, Vizeacoumar FS, Abuhussein O, Maranda V, Zhang Y, Adachi H, Nguyen K, Kyrylenko L, Rangel-Pozzo A, Dong H, Gong L, Materi A, Walke P, Ganapathysamy A, Denomy C, Freywald T, Dahiya R, Elhasasna H, Saxena A, Vizeacoumar JP, Patel H, Rajamanickam K, de Oliveira DM, Lazell-Wright M, Morales AM, Aggarwal A, Xu JL, Alli N, Munhoz EP, Gao P, Salsman J, Dahiya DK, Kola NS, Gonzalez-Lopez C, Thibault P, Levin M, Dellaire G, Jette N, Groot G, Köbel M, Lee CH, Hopkins L, Krishnan A, Ahmed S, Eskiw C, Barakat KH, Thakur A, Wu Y, DePinho RA, Mai S, Yu YT, Wong JMY, Freywald A, Vizeacoumar FJ

Signal transduction and targeted therapy2026

DOI: 10.1038/s41392-026-02750-0 PMID: 42236690

MDS/AML-associated DDX41 helicase facilitates homologous recombination repair by potentially resolving R-loops.

Aggarwal A, Yang S, Winstone L, Mondal S, Grainger H, Singh RS, Arna AB, Vizeacoumar FJ, Wu Y

Nucleic acids research2026Senior author

DOI: 10.1093/nar/gkag219 PMID: 41816910

A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.

Walke P, Price JDW, Vizeacoumar FS, Joseph N, Maranda V, Chowdhury B, Patel J, Zhang Y, Dong H, New L, Ganapathysamy A, Gong LH, Lazell-Wright M, Elhasasna H, Bhanumathy KK, Wu Y, Wang Y, Freywald A, Krishnan A, Vizeacoumar FJ

Oncogene2025

DOI: 10.1038/s41388-025-03413-0 PMID: 40301542

Catch me if you can: viral nucleic acids to host sensors.

Jung Y, Grainger H, Yang S, Mondal S, Lukong KE, Conn K, Wu Y

Frontiers in immunology2025Senior author

DOI: 10.3389/fimmu.2025.1632283 PMID: 40791597

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

Cunningham CE, Vizeacoumar FS, Zhang Y, Kyrylenko L, Both S, Maranda V, Dong H, Price JDW, Gao P, Wagner K, Wu Y, Lazell-Wright M, Ganapathysamy A, Hari R, Bhanumathy KK, Denomy C, Saxena A, Vizeacoumar JP, Morales AM, Khan F, Mosley S, Chen A, Katrii T, Zoller BGE, Rajamanickam K, Walke P, Gong L, Patel H, Elhasasna H, Dahiya R, Abuhussein O, Dmitriev A, Freywald T, Munhoz EP, Ruppin E, Lee JS, Rox K, Koebel M, Hopkins L, Lee CH, Yadav S, Gasparoni G, Walter J, Krishnan A, Datla R, Toosi B, Baker K, Meens J, Cescon DW, Ailles L, Leary SC, Wu Y, Empting M, Kiemer AK, Freywald A, Vizeacoumar FJ

Cell genomics2025

DOI: 10.1016/j.xgen.2025.100876 PMID: 40347943

DDX41: exploring the roles of a versatile helicase.

Winstone L, Jung Y, Wu Y

Biochemical Society transactions2024Senior author

DOI: 10.1042/bst20230725 PMID: 38348889

Purification and biochemical characterization of the G4 resolvase and DNA helicase FANCJ.

Kulikowicz T, Sommers JA, Fuchs KF, Wu Y, Brosh RM

Methods in enzymology2024

DOI: 10.1016/bs.mie.2023.12.006 PMID: 38521581

Helicases in R-loop Formation and Resolution.

Yang S, Winstone L, Mondal S, Wu Y

The Journal of biological chemistry2023Senior author

DOI: 10.1016/j.jbc.2023.105307 PMID: 37778731

Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy.

Arna AB, Patel H, Singh RS, Vizeacoumar FS, Kusalik A, Freywald A, Vizeacoumar FJ, Wu Y

Frontiers in oncology2022Senior author

DOI: 10.3389/fonc.2022.1087989 PMID: 36761420

Structure-function analysis of DEAD-box helicase DDX43.

Singh RS, Arna AB, Dong H, Yadav M, Aggarwal A, Wu Y

Methods (San Diego, Calif.)2022Senior author

DOI: 10.1016/j.ymeth.2022.03.002 PMID: 35257897

Something wrong or missing on this profile? Suggest a correction

Yuliang Wu

Research

Latest papers

Latest funding

Epigenetic control of telomeric RNA maintains heterochromatin in telomerase-driven cancers.

MDS/AML-associated DDX41 helicase facilitates homologous recombination repair by potentially resolving R-loops.

A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancer.

Catch me if you can: viral nucleic acids to host sensors.

Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality.

DDX41: exploring the roles of a versatile helicase.

Purification and biochemical characterization of the G4 resolvase and DNA helicase FANCJ.

Helicases in R-loop Formation and Resolution.

Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy.

Structure-function analysis of DEAD-box helicase DDX43.

Understanding the Role of KH Domain in Helicases

The role of Q motif in superfamily 2 DNA helicases

Frequent collaborators

Andrew Freywald

Anand Krishnan

Anthony Kusalik

Michael Levin

Kristen Conn

Jim Xiang

Graham Dellaire

Kristi Baker

Shahid Ahmed

Yan Zhou

Christopher Eskiw

Gary Groot

Aneesh Thakur

Jie Han

Yuzhuo Wang

Vikram Misra

Sabine Mai

Laurie Ailles